TNPSC Thervupettagam

Nasal spray for COVID-19

November 29 , 2021 1017 days 583 0
  • ITC is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.
  • It is developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru.
  • The company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories